Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Rebibou

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
La Revue Du Praticien|January 23, 2026
[Kidney xenotransplant, a real alternative?]Cyrille Guillot-Tantay, Jean-Michel Rebibou
Transplantation|January 1, 2008
Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and overEmilie Savoye, Dorothée Tamarelle, Ylana Chalem, et al.
European Journal of Haematology|October 22, 2022
Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpuraCeline Comparon, Lionel Galicier, Jean Michel Rebibou, et al.
Transplantation Reviews (Orlando, Fla.)|May 1, 2017
Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged swordJamal Bamoulid, Thomas Crépin, Cécile Courivaud, et al.
Cell Transplantation|November 9, 2017
Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated AtherosclerosisDidier Ducloux, Jamal Bamoulid, Thomas Crepin, et al.
Journal of Nephrology|March 12, 2015
Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patientsCécile Courivaud, Karine Bardonnet, Thomas Crepin, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Changing kidney allocation policy in France: the value of simulationChristian Jacquelinet, Benoît Audry, Christiine Golbreich, et al.
Immunity & Ageing : I & A|July 21, 2018
ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implicationsDidier Ducloux, Mathieu Legendre, Jamal Bamoulid, et al.
Human Immunology|November 17, 2009
Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantationEmeline Masson, Nadège Devillard, Jacqueline Chabod, et al.
Haematologica|April 12, 2005
Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantationEric Deconinck, Marc Kribs, Jean-Michel Rebibou, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
La Revue Du Praticien|January 23, 2026
[Kidney xenotransplant, a real alternative?]Cyrille Guillot-Tantay, Jean-Michel Rebibou
Transplantation|January 1, 2008
Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and overEmilie Savoye, Dorothée Tamarelle, Ylana Chalem, et al.
European Journal of Haematology|October 22, 2022
Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpuraCeline Comparon, Lionel Galicier, Jean Michel Rebibou, et al.
Transplantation Reviews (Orlando, Fla.)|May 1, 2017
Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged swordJamal Bamoulid, Thomas Crépin, Cécile Courivaud, et al.
Cell Transplantation|November 9, 2017
Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated AtherosclerosisDidier Ducloux, Jamal Bamoulid, Thomas Crepin, et al.
Journal of Nephrology|March 12, 2015
Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patientsCécile Courivaud, Karine Bardonnet, Thomas Crepin, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Changing kidney allocation policy in France: the value of simulationChristian Jacquelinet, Benoît Audry, Christiine Golbreich, et al.
Immunity & Ageing : I & A|July 21, 2018
ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implicationsDidier Ducloux, Mathieu Legendre, Jamal Bamoulid, et al.
Human Immunology|November 17, 2009
Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantationEmeline Masson, Nadège Devillard, Jacqueline Chabod, et al.
Haematologica|April 12, 2005
Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantationEric Deconinck, Marc Kribs, Jean-Michel Rebibou, et al.
Pageof 5